YABAO Pharmaceuticals (600351.SH) released its semi-annual performance report, with a net profit attributable to shareholders of 174 million yuan, a year-on-year decrease of 2.99%.

The financial news app, Securities Times APP, reported that Yabao Pharmaceutical (600351.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 1.139 billion yuan, a year-on-year decrease of 21.08%; the net profit attributable to shareholders of the listed company was 174 million yuan, a year-on-year decrease of 2.99%; the non-recurring net profit was 160 million yuan, a year-on-year decrease of 1.69%; and the basic earnings per share were 0.2483 yuan.